Assembly Bio Reports Phase 1b Success in Herpes; Gilead Increases Stake with 2.3M Shares

Assembly Bio; Phase 1b trial; ABI-5366; herpes simplex virus (HSV-2); viral shedding reduction; genital lesion reduction; safety profile; Gilead Sciences; collaboration; stock purchase

AbbVie and Genmab Move to Expand Use of T Cell Engager Epkinly Following Strong Phase III Results

Epkinly; epcoritamab; AbbVie; Genmab; follicular lymphoma; T cell engager; bispecific antibody; Phase III trial; FDA approval; label expansion; Rituximab; Lenalidomide

Two Courts Reject Challenges to Inflation Reduction Act, Marking Major Win for Government

Inflation Reduction Act; IRA; Medicare Drug Negotiation Program; AstraZeneca; federal courts; constitutional challenge; administrative law; Third Circuit Court; CMS; Medicare

FDA Launches PreCheck Program to Accelerate Domestic Drug Manufacturing

FDA PreCheck; domestic drug manufacturing; pharmaceutical supply chain; API; regulatory streamlining; facility construction; national security; Trump administration